NCT05505565Completed

Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes

Continuous Glucose Monitors in the Management of Youth With Prediabetes

Source: ClinicalTrials.gov · Last updated 17 Jun 2026

Brief summary (registry, in English)

We are evaluating whether intermittent use of continuous glucose monitors (CGMs) in addition to standard nutritional counseling and physical activity counseling is associated with improved metabolic health for youth with pre-diabetes (PD).

Status (registry): Completed
Study type: Interventional
Enrollment: 54 (actual)
First submitted: 15 Aug 2022
Start date: 5 Jun 2023
Primary completion date: 15 May 2025
Lead sponsor: University of Alabama at Birmingham
Diseases: Obesity
NCT number: NCT05505565

What you commit to

Study type: Interventional
Participants enrolled: 54
From 5 Jun 2023 to the primary completion date, 15 May 2025
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

chronic steroid use

Other illness

diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes
current or history of malignancy

Age

BMI \< 85% for age

Who the study is looking for

Age 11 or older
English-speaking
stable metformin dose for 1 month prior to enrollment or no metformin use
baseline A1c of 5.7-6.4%
BMI \> = 85% for age

Age in the registry: 11 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

Site	City	Country	Site status
Children's of Alabama Coordinator of this site? Confirm its status	Birmingham	United States	Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.